DNA Link Balance Sheet Health
Financial Health criteria checks 5/6
DNA Link has a total shareholder equity of ₩23.6B and total debt of ₩6.1B, which brings its debt-to-equity ratio to 25.8%. Its total assets and total liabilities are ₩40.9B and ₩17.3B respectively.
Key information
25.8%
Debt to equity ratio
₩6.09b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩2.93b |
| Equity | ₩23.61b |
| Total liabilities | ₩17.32b |
| Total assets | ₩40.93b |
Recent financial health updates
Recent updates
DNA Link, Inc. (KOSDAQ:127120) Shares Fly 27% But Investors Aren't Buying For Growth
Jul 12
There Is A Reason DNA Link, Inc.'s (KOSDAQ:127120) Price Is Undemanding
Mar 19Is DNA Link (KOSDAQ:127120) Using Too Much Debt?
Apr 19Introducing DNA Link (KOSDAQ:127120), A Stock That Climbed 61% In The Last Year
Feb 23Financial Position Analysis
Short Term Liabilities: A127120's short term assets (₩12.6B) do not cover its short term liabilities (₩13.7B).
Long Term Liabilities: A127120's short term assets (₩12.6B) exceed its long term liabilities (₩3.6B).
Debt to Equity History and Analysis
Debt Level: A127120's net debt to equity ratio (13.4%) is considered satisfactory.
Reducing Debt: A127120's debt to equity ratio has reduced from 53.2% to 25.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A127120 has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: A127120 is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.